Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial
  2. Kasirye, Ronnie; Hume, Heather A; Bloch, Evan M; Lubega, Irene; Kyeyune, Dorothy; Shrestha, Ruchee; Ddungu, Henry; Musana, Hellen Wambongo; Dhabangi, Aggrey; Ouma, Joseph; Eroju, Priscilla; de Lange, Telsa; Tartakovsky, Michael; White, Jodie L; Kakura, Ceasar; Fowler, Mary Glenn; Musoke, Philippa; Nolan, Monica; Grabowski, M Kate; Moulton, Lawrence H; Stramer, Susan L; Whitby,Denise; Zimmerman, Peter A; Wabwire, Deo; Kajja, Isaac; McCullough, Jeffrey; Goodrich, Raymond; Quinn, Thomas C; Cortes, Robert; Ness, Paul M; Tobian, Aaron A R
  3. Trials. 2022, Apr 04; 23(1):
  1. 2.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 3.   Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian Clinics
  2. Martins, A. N.; Arruda, M. B.; Aleixo, A. W.; Pires, A. F.; Greco, D. B.; Brindeiro, R. D.; Tanuri, A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2011, Aug; 57: S193-S196.
  1. 4.   The Nonnucleoside Reverse Transcriptase Inhibitor MIV-150 in Carrageenan Gel Prevents Rectal Transmission of Simian/Human Immunodeficiency Virus Infection in Macaques
  2. Singer, R.; Derby, N.; Rodriguez, A.; Kizima, L.; Kenney, J.; Aravantinou, M.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Journal of Virology. 2011, Jun; 85(11): 5504-5512.
  1. 5.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 6.   Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production
  2. Mannon, P. J.; Hornung, R. L.; Yang, Z. Q.; Yi, C. L.; Groden, C.; Friend, J.; Yao, M.; Strober, W.; Fuss, I. J.
  3. Gut. 2011, Apr; 60(4): 449-455.
  1. 7.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
  1. 8.   An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
  2. Kenney, J.; Aravantinou, M.; Singer, R.; Hsu, M.; Rodriguez, A.; Kizima, L.; Abraham, C. J.; Menon, R.; Seidor, S.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 9.   Update on D-Ala-Peptide T-Amide (DAPTA): A viral entry inhibitor that blocks CCR5 chemokine receptors
  2. Ruff, M. R.; Polianova, M.; Yang, Q. E.; Leoung, G. S.; Ruscetti, F. W.; Pert, C. B.
  3. Current HIV Research. 2003 1(1): 51-67.
  1. 10.   Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells
  2. Sereti, I.; Martinez-Wilson, H.; Metcalf, J. A.; Baseler, M. W.; Hallahan, C. W.; Hahn, B.; Hengel, R. L.; Davey, R. T.; Kovacs, J. A.; Lane, H. C.
  3. Blood. 2002 100(6): 2159-2167.
  1. 11.   CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients
  2. Sereti, I.; Herpin, B.; Metcalf, J. A.; Stevens, R.; Baseler, M. W.; Hallahan, C. W.; Kovacs, J. A.; Davey, R. T.; Lane, H. C.
  3. Aids. 2001 15(14): 1765-1775.
  1. 12.   Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression
  2. Kovacs, J. A.; Imamichi, H.; Vogel, S.; Metcalf, J. A.; Dewar, R. L.; Baseler, M.; Stevens, R.; Adelsberger, J.; Lambert, L.; Davey, R. T.; Walker, R. E.; Falloon, J.; Polis, M. A.; Masur, H.; Lane, H. C.
  3. Journal of Infectious Diseases. 2000 182(4): 1063-1069.
  1. 13.   Pilot Study of the Immunologic Effects of Recombinant Human Growth Hormone and Recombinant Insulin-Like Growth Factor in Hiv-Infected Patients
  2. Nguyen, B. Y.; Clerici, M.; Venzon, D. J.; Bauza, S.; Murphy, W. J.; Longo, D. L.; Baseler, M.; Gesundheit, N.; Broder, S.; Shearer, G.; Yarchoan, R.
  3. Aids. 1998 12(8): 895-904.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel